JP2016503063A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016503063A5 JP2016503063A5 JP2015549772A JP2015549772A JP2016503063A5 JP 2016503063 A5 JP2016503063 A5 JP 2016503063A5 JP 2015549772 A JP2015549772 A JP 2015549772A JP 2015549772 A JP2015549772 A JP 2015549772A JP 2016503063 A5 JP2016503063 A5 JP 2016503063A5
- Authority
- JP
- Japan
- Prior art keywords
- isc
- cetuximab
- prodrug
- therapeutic agent
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261740126P | 2012-12-20 | 2012-12-20 | |
| US61/740,126 | 2012-12-20 | ||
| PCT/US2013/076869 WO2014100565A1 (en) | 2012-12-20 | 2013-12-20 | Methods and compositions relating to treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016503063A JP2016503063A (ja) | 2016-02-01 |
| JP2016503063A5 true JP2016503063A5 (https=) | 2017-01-26 |
Family
ID=49950064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015549772A Pending JP2016503063A (ja) | 2012-12-20 | 2013-12-20 | がんの治療に関する方法及び組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20150328310A1 (https=) |
| EP (1) | EP2934583A1 (https=) |
| JP (1) | JP2016503063A (https=) |
| KR (1) | KR20150099588A (https=) |
| CN (1) | CN105007940B (https=) |
| AU (1) | AU2013361164A1 (https=) |
| CA (1) | CA2894547A1 (https=) |
| RU (1) | RU2015129366A (https=) |
| SG (1) | SG11201504779YA (https=) |
| WO (1) | WO2014100565A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA45547A (fr) | 2016-06-29 | 2019-05-08 | Principia Biopharma Inc | Formulations à libération modifiée à base de 2-[3-[4-amino-3-(2-fluoro-4-phénoxy-phényl)pyrazolo[3,4-d]pyrimidine-1-yl]pipéridine-1-carbonyl]-4-méthyl-4-[4-(oxétane-3-yl)pipérazine-1-yl]pent-2-ènenitrile |
| TWI877239B (zh) | 2019-10-14 | 2025-03-21 | 美商普林斯匹亞生物製藥公司 | 藉由投予(R)-2-[3-[4-胺基-3-(2-氟-4-苯氧基-苯基)吡唑并[3,4-d]嘧啶-1-基]哌啶-1-羰基]-4-甲基-4-[4-(氧呾-3-基)哌-1-基]戊-2-烯腈來治療免疫血小板減少症之方法 |
| JP2023511105A (ja) | 2020-01-22 | 2023-03-16 | プリンシピア バイオファーマ インコーポレイテッド | ２－［３－［４－アミノ－３－（２－フルオロ－４－フェノキシ－フェニル）－１ｈ－ピラゾロ［３，４－ｄ］ピリミジン－１－イル］ピペリジン－１－カルボニル］－４－メチル－４－［４－（オキセタン－３－イル）ピペラジン－１－イル］ペンタ－２－エンニトリルの結晶形態 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9407386D0 (en) | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
| US5648097A (en) | 1995-10-04 | 1997-07-15 | Biotek, Inc. | Calcium mineral-based microparticles and method for the production thereof |
| US6391336B1 (en) | 1997-09-22 | 2002-05-21 | Royer Biomedical, Inc. | Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| US20080306148A1 (en) * | 2007-04-13 | 2008-12-11 | The Penn State Research Foundation | Anti-cancer compositions and methods |
-
2013
- 2013-12-20 KR KR1020157019739A patent/KR20150099588A/ko not_active Withdrawn
- 2013-12-20 CA CA2894547A patent/CA2894547A1/en not_active Abandoned
- 2013-12-20 CN CN201380073538.9A patent/CN105007940B/zh not_active Expired - Fee Related
- 2013-12-20 WO PCT/US2013/076869 patent/WO2014100565A1/en not_active Ceased
- 2013-12-20 JP JP2015549772A patent/JP2016503063A/ja active Pending
- 2013-12-20 SG SG11201504779YA patent/SG11201504779YA/en unknown
- 2013-12-20 AU AU2013361164A patent/AU2013361164A1/en not_active Abandoned
- 2013-12-20 US US14/652,363 patent/US20150328310A1/en not_active Abandoned
- 2013-12-20 RU RU2015129366A patent/RU2015129366A/ru not_active Application Discontinuation
- 2013-12-20 EP EP13819149.9A patent/EP2934583A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7562296B2 (ja) | がんの処置のための併用治療 | |
| RU2757373C2 (ru) | Комбинированная терапия противоопухолевым алкалоидом | |
| JP2015523397A5 (https=) | ||
| Löhr et al. | A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination with gemcitabine in chemotherapy-naive patients with unresectable pancreatic cancer | |
| JP6675313B2 (ja) | 組合せ医薬 | |
| CL2018001371A1 (es) | Uso de un inhibidor de b-raf y de un inhibidor de mek 1/2 para el tratamiento de un paciente que padece melanoma (divisional solicitud 201502807) | |
| EA030465B1 (ru) | Комбинированная терапия, включающая ингибитор cdk4/6 и ингибитор pi3k для применения в лечении рака | |
| JP2016529285A5 (https=) | ||
| JP2019516711A5 (https=) | ||
| JP2014132009A5 (https=) | ||
| FI3377534T3 (fi) | Keuhkosyövän hoito käyttäen anti-pd-1-vasta-aineen ja anti-ctla-4-vasta-aineen yhdistelmää | |
| JP2017504611A5 (https=) | ||
| JP2016515628A5 (https=) | ||
| RU2014135436A (ru) | Комбинация ингибитора rtk с антиэстрогеном и ее применение для лечения рака | |
| JP2015502926A5 (https=) | ||
| JP2014525454A5 (https=) | ||
| JP2017533963A5 (https=) | ||
| MX2022011372A (es) | Composiciones de zinc-y-pga y metodos para tratar el cancer. | |
| WO2009149166A3 (en) | Methods and compositions for the diagnosis and treatment of proliferative disorders | |
| AR078170A1 (es) | Metodos para el tratamiento de tumores cerebrales | |
| JP2016503063A5 (https=) | ||
| Chang et al. | Combined therapeutic efficacy of 188Re-liposomes and sorafenib in an experimental colorectal cancer liver metastasis model by intrasplenic injection of C26-luc murine colon cancer cells | |
| WO2015035410A8 (en) | Cancer therapy | |
| KR20140040769A (ko) | 조합 요법 | |
| JP2017527627A (ja) | 喫煙者における非小細胞肺癌の治療のための、カルボプラチンおよびパクリタキセルと併用したベリパリブ |